Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Management of metastatic renal cell carcinomass].
Rolley C, Aubert C, Baize N, Bigot P. Rolley C, et al. Prog Urol. 2018 Nov;28(14):777-782. doi: 10.1016/j.purol.2018.07.280. Epub 2018 Aug 31. Prog Urol. 2018. PMID: 30174169 French.
Ketogenic diet enhances the anti-cancer effects of PD-L1 blockade in renal cell carcinoma.
Richard J, Beauvillain C, Benoit M, Barth M, Aubert C, Rolley C, Bellal S, Bourreau J, Ferragu M, Lebdai S, Chevrollier A, Henrion D, Procaccio V, Bigot P. Richard J, et al. Among authors: rolley c. Front Endocrinol (Lausanne). 2024 May 17;15:1344891. doi: 10.3389/fendo.2024.1344891. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38846490 Free PMC article.
[Impact of delay before partial nephrectomy of a localized kidney tumor].
Benmeziani R, Royer M, Aubert C, Rolley C, Le Corre V, Culty T, Nedelcu C, Zidane M, Lebdai S, Bigot P. Benmeziani R, et al. Among authors: rolley c. Bull Cancer. 2023 Feb;110(2):160-167. doi: 10.1016/j.bulcan.2022.08.006. Epub 2022 Nov 12. Bull Cancer. 2023. PMID: 36379731 French.
Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv-UroCCR 79 Study.
Rolley C, Barthelemy P, Bensalah K, Nouhaud FX, Villers A, Bruyère F, Lebdai S, Ricard S, Gross-Goupil M, Rouprêt M, Bernhard JC, Bigot P. Rolley C, et al. Clin Genitourin Cancer. 2023 Feb;21(1):194-202. doi: 10.1016/j.clgc.2022.07.002. Epub 2022 Jul 9. Clin Genitourin Cancer. 2023. PMID: 35931600